Real-world clinical outcomes in BRCA-positive metastatic breast cancer patients treated in the community oncology setting

被引:0
|
作者
Houts, Arthur C.
Olufade, Temitope O.
Shenolikar, Rahul
Walker, Mark S.
机构
[1] Vector Oncol, Memphis, TN USA
[2] AstraZeneca, Gaithersburg, MD USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P4-09-15
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Real-world clinical outcomes of patients with stage I HER2-positive breast cancer treated with adjuvant paclitaxel and trastuzumab
    Debien, Veronique
    Marta, Guilherme Nader
    Agostinetto, Elisa
    Sirico, Marianna
    Jacobs, Flavia
    Molinelli, Chiara
    Moreau, Michel
    Paesmans, Marianne
    De Giorgi, Ugo
    Santoro, Armando
    Taylor, Donatienne
    Duhoux, Francois P.
    Botticelli, Andrea
    Barchiesi, Giacomo
    Speranza, Iolanda
    Lambertini, Matteo
    Wildiers, Hans
    de Azambuja, Evandro
    Piccart, Martine
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2023, 190
  • [32] A real-world study of treatment sequences and second-line clinical outcomes in patients with HER2-positive metastatic breast cancer in US community practice
    Varghese, Della
    Cruz, Giovanna I.
    Johanson, Colden
    Toland, Liz
    Miranda, Miguel
    Faherty, Eleanor C.
    Harland, David
    Kaplan, Henry G.
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2024, 29 (06) : 780 - 789
  • [33] Real-world effectiveness outcomes by race in patients with metastatic triple negative breast cancer
    Skinner, K. E.
    Dufour, R.
    Haiderali, A.
    Huang, M.
    Schwartzberg, L. S.
    CANCER RESEARCH, 2019, 79 (04)
  • [34] Impact of homologous recombination repair/BReast CAncer (BRCA) gene alterations on survival in a real-world setting of metastatic prostate cancer
    Wenzel, Mike
    Hoeh, Benedikt
    Koll, Florestan
    Humke, Clara
    Fassl, Anne
    Reis, Henning
    Wild, Peter
    Steuber, Thomas
    Graefen, Markus
    Tilki, Derya
    Traumann, Miriam
    Banek, Severine
    Chun, Felix K. H.
    Mandel, Philipp
    BJU INTERNATIONAL, 2025, 135 (01) : 117 - 124
  • [35] Real-world study of treatment patterns and clinical outcomes in patients with metastatic non-small cell lung cancer (mNSCLC) post-approval of immunotherapy in the community oncology setting
    Spira, Alexander I.
    Korytowsky, Beata
    Gao, Sara
    Dubois, Renard
    Wilson, Thomas
    Osterland, Andrew
    Shi, Junxin
    Conkling, Paul R.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [36] Ixabepilone efficacy and tolerability in metastatic breast cancer (MBC) patients in a real-world setting.
    Hyder, Tara
    Rosenzweig, Margaret Q.
    Brufsky, Adam
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [37] Real-world treatment patterns among metastatic breast cancer patients by BRCA status and phenotype.
    Sebby, Wendy
    Liede, Alexander
    Mazumder, Debasish
    Ghosh, Anirban
    Papademetriou, Eros
    Potluri, Ravi C.
    Bach, Bruce Allen
    Tyczynski, Jerzy Edward
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [38] Chemotherapy-related complication burden in patients with metastatic breast cancer in a real-world setting
    Hurvitz, S. A.
    Lalla, D.
    Guerin, A.
    Latremouille-Viau, D.
    Yu, A. P.
    Wu, E. Q.
    Brammer, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [39] Real-world study of patients with locally advanced HNSCC in the community oncology setting
    Black, Christopher M.
    Ramakrishnan, Karthik
    Nadler, Eric
    Tseng, Wan-Yu
    Wentworth, Chuck
    Murphy, John
    Fulcher, Nicole
    Wang, Liya
    Alexander, Melannie
    Patton, Gregory
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [40] Real-world treatment patterns, health care utilization, and costs associatedwith recurrence in germline BRCA-positive ovarian cancer
    Shenolikar, R.
    Davis, K. L.
    Nagar, S.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 121 - 121